- Home
- WHWK vs ACH Comparison
WHWK vs ACH Comparison
Compare WHWK & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHWK | ACH |
|---|---|---|
| Founded | 2007 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 217.5M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WHWK | ACH |
|---|---|---|
| Price | $4.19 | $1.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $7.50 | $3.38 |
| AVG Volume (30 Days) | 243.4K | ★ 1.7M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,145,000.00 | ★ $2,762,032,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.80 | $0.93 |
| 52 Week High | $5.50 | $4.69 |
Technical Indicators
Market Signals| Indicator | WHWK | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 40.38 | 28.94 |
| Support Level | $3.79 | $0.93 |
| Resistance Level | $4.38 | $1.37 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 5.32 | 1.67 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About ACH Accendra Health Inc.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.